108 — SR Medical Technology Share Price
Last trade - 00:00- HK$9.17bn
- HK$12.08bn
- HK$327.91m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.38 | ||
| Price to Tang. Book | 5.2 | ||
| Price to Free Cashflow | 31.59 | ||
| Price to Sales | 24.1 | ||
| EV to EBITDA | 479.65 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -0.57% | ||
| Return on Equity | -8.51% | ||
| Operating Margin | -6.93% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | HK$m | 331.33 | 352.28 | 352.64 | 310.02 | 327.91 | n/a | n/a | 2.04% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +535.71 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
SR Medical Technology Co Ltd, formerly GR Life Style Co Ltd, is an investment holding company principally engaged in property-related businesses. The Company operates through two segments. The Property Development And Investment segment engages in property development and investment. The Property Management segment engages in the provision of property management and other services for office buildings, residential properties and car parks.
Directors
- Chunxian Wei CHM (56)
- Bing Li EDR
- Zhongmin Sun EDR (52)
- Yuen Ling Lam SEC (54)
- Ho Ming Leung NID (37)
- Tsz Wan To NID (48)
- Woon Cheung Tung NID (50)
- Last Annual
- December 31st, 2025
- Last Interim
- June 30th, 2026
- Incorporated
- January 16th, 1973
- Public Since
- February 9th, 1973
- No. of Employees
- 495
- Sector
- Real Estate Operations
- Industry
- Financials
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 3,321,373,986
- Address
- Unit 3505,
- Web
- https://www.grlifestyle.com.hk/
- Phone
- +852 null36197267
- Auditors
- Ernst & Young CPA
Latest News for 108
Upcoming Events for 108
Similar to 108
Agile group
Stock Exchange of Hong Kong Limited
A-Living Smart City Services
Stock Exchange of Hong Kong Limited
Altus Holdings
Stock Exchange of Hong Kong Limited
Art group
Stock Exchange of Hong Kong Limited
Asiasec Properties
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 05:28 UTC, shares in SR Medical Technology are trading at HK$2.76. This share price information is delayed by 15 minutes.
Shares in SR Medical Technology last closed at HK$2.76 and the price had moved by +41.54% over the past 365 days. In terms of relative price strength the SR Medical Technology share price has outperformed the FTSE Developed Asia Pacific Index by +3.38% over the past year.
There is no consensus recommendation for this security.
Find out moreSR Medical Technology does not currently pay a dividend.
SR Medical Technology does not currently pay a dividend.
SR Medical Technology does not currently pay a dividend.
To buy shares in SR Medical Technology you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$2.76, shares in SR Medical Technology had a market capitalisation of HK$9.17bn.
Here are the trading details for SR Medical Technology:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 108
Based on an overall assessment of its quality, value and momentum SR Medical Technology is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like SR Medical Technology. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -7.8%.
As of the last closing price of HK$2.76, shares in SR Medical Technology were trading +18.74% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The SR Medical Technology PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$2.76.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
SR Medical Technology's management team is headed by:
- Chunxian Wei - CHM
- Bing Li - EDR
- Zhongmin Sun - EDR
- Yuen Ling Lam - SEC
- Ho Ming Leung - NID
- Tsz Wan To - NID
- Woon Cheung Tung - NID